MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:MBX - CA59501P1045 - Common Stock
MBX.CA Key Statistics, Chart & Performance
The current stock price of MBX.CA is 0.25 CAD. In the past month the price increased by 2.04%. In the past year, price decreased by -16.67%.
MBX.CA Latest News, Press Relases and Analysis
MBX.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 449.77M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 385.84M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 177.20M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 115.94M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 24.25 | 53.19M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 32.98M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 21.30M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 15.64M | ||
| MPH.CA | MEDICURE INC | N/A | 13.57M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 9.75M | ||
| QPT.CA | QUEST PHARMATECH INC | N/A | 7.61M | ||
| APS.CA | APTOSE BIOSCIENCES INC | N/A | 5.89M |
Related stock screener links
About MBX.CA
Company Profile
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm develops and commercializes proprietary biological and technology solutions for human health and wellbeing. The company manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The firm operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.
Company Info
MICROBIX BIOSYSTEMS INC
265 Watline Avenue
Mississauga ONTARIO L4Z 1P3 CA
CEO: Cameron Groome
Employees: 0
Phone: 19053618910
MICROBIX BIOSYSTEMS INC / MBX.CA FAQ
What does MICROBIX BIOSYSTEMS INC do?
Microbix Biosystems, Inc. engages in developing and commercializing proprietary biological and technology solutions for human health and wellbeing. The company is headquartered in Mississauga, Ontario. The firm develops and commercializes proprietary biological and technology solutions for human health and wellbeing. The company manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The firm operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.
Can you provide the latest stock price for MICROBIX BIOSYSTEMS INC?
The current stock price of MBX.CA is 0.25 CAD. The price increased by 6.38% in the last trading session.
Does MBX stock pay dividends?
MBX.CA does not pay a dividend.
How is the ChartMill rating for MICROBIX BIOSYSTEMS INC?
MBX.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the upcoming earnings date for MICROBIX BIOSYSTEMS INC?
MICROBIX BIOSYSTEMS INC (MBX.CA) will report earnings on 2025-12-18.
Who owns MICROBIX BIOSYSTEMS INC?
You can find the ownership structure of MICROBIX BIOSYSTEMS INC (MBX.CA) on the Ownership tab.
MBX.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MBX.CA. When comparing the yearly performance of all stocks, MBX.CA is a bad performer in the overall market: 79.16% of all stocks are doing better.
MBX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MBX.CA. MBX.CA scores excellent on profitability, but there are some minor concerns on its financial health.
MBX.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.85% | ||
| ROE | -1.11% | ||
| Debt/Equity | 0.21 |
MBX.CA Forecast & Estimates
5 analysts have analysed MBX.CA and the average price target is 0.92 CAD. This implies a price increase of 267.2% is expected in the next year compared to the current price of 0.25.
For the next year, analysts expect an EPS growth of 50% and a revenue growth 7.14% for MBX.CA